Noesis Capital Mangement Corp Has $15.11 Million Stake in Agilent Technologies, Inc. $A

Noesis Capital Mangement Corp grew its stake in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 4.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 132,538 shares of the medical research company’s stock after buying an additional 6,006 shares during the period. Agilent Technologies makes up 2.2% of Noesis Capital Mangement Corp’s portfolio, making the stock its 22nd biggest position. Noesis Capital Mangement Corp’s holdings in Agilent Technologies were worth $15,107,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. SHP Wealth Management acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $26,000. Core Wealth Advisors LLC acquired a new position in Agilent Technologies during the fourth quarter valued at approximately $26,000. Board of the Pension Protection Fund acquired a new position in Agilent Technologies during the fourth quarter valued at approximately $27,000. Navalign LLC bought a new stake in Agilent Technologies in the fourth quarter valued at approximately $27,000. Finally, MV Capital Management Inc. bought a new stake in Agilent Technologies in the fourth quarter valued at approximately $28,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Trading Down 0.2%

Shares of NYSE:A opened at $134.92 on Thursday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The company’s fifty day simple moving average is $126.82 and its 200 day simple moving average is $125.60. The firm has a market cap of $38.11 billion, a price-to-earnings ratio of 27.09, a PEG ratio of 2.40 and a beta of 1.25.

Agilent Technologies (NYSE:AGet Free Report) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be given a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on A shares. Jefferies Financial Group started coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price on the stock. Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective for the company. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Piper Sandler started coverage on Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Finally, Robert W. Baird boosted their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $159.35.

View Our Latest Research Report on A

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.